How Long Can You Stay on Eliquis?

Understanding Eliquis Treatment Duration

Eliquis (apixaban) is a blood thinner that prevents dangerous blood clots and strokes. Many patients wonder how long they can stay on this medication safely. The answer depends on your specific medical condition, risk factors, and individual response to treatment. Some patients take it for weeks or months, while others may need it for years or even lifelong.

Short-Term Eliquis Use After Surgery

For patients who undergo hip or knee replacement surgery, Eliquis is typically prescribed for a specific, limited time period. After hip replacement surgery, treatment usually lasts 35 days. For knee replacement, the duration is often shorter, typically 12 days.

These timeframes are based on when the risk of blood clots is highest after surgery. Once you become more mobile and your surgical site heals, the clot risk decreases significantly. Your surgeon will determine the exact duration based on your recovery progress and individual risk factors.

Blood Clot Treatment Duration

When Eliquis is used to treat existing blood clots like deep vein thrombosis (DVT) or pulmonary embolism (PE), the treatment approach happens in phases.

Initial Treatment Phase

The first phase involves higher doses for the first seven days, followed by a maintenance dose for at least six months. This initial period ensures the existing clot is properly treated and prevented from growing larger.

Extended Prevention Phase

After completing at least six months of treatment, your doctor may recommend extended therapy using a lower dose. This reduced dose (typically 2.5 mg twice daily) helps prevent new clots from forming while reducing bleeding risk.

The decision to continue extended therapy depends on your risk of developing new clots versus your risk of bleeding complications. Some patients may need this extended treatment for several additional years.

Long-Term Use for Atrial Fibrillation

Patients with atrial fibrillation (AFib) often require the longest treatment durations. AFib causes irregular heartbeats that can lead to blood pooling in the heart chambers, creating clots that may travel to the brain and cause strokes.

For nonvalvular atrial fibrillation, Eliquis is typically prescribed indefinitely to prevent stroke and systemic embolism. Unlike temporary conditions, AFib is usually a chronic condition that requires ongoing stroke prevention.

Many physicians recommend lifelong anticoagulation for AFib patients to maintain stroke protection. The decision is based on your individual stroke risk score and bleeding risk assessment.

Factors That Influence Treatment Duration

Several factors help determine how long you should stay on Eliquis:

• Your underlying condition: Temporary conditions like post-surgical clot risk require shorter treatment than chronic conditions like AFib.
• Clot recurrence risk: If you have had multiple blood clots or certain genetic conditions, longer treatment may be necessary.
• Bleeding risk: Your age, kidney function, and history of bleeding problems influence how long treatment is safe.
• Other medical conditions: Heart disease, cancer, or mobility issues may increase your need for continued anticoagulation.
• Response to treatment: How well you tolerate the medication and whether you experience side effects affects duration decisions.

Why You Cannot Stop Eliquis Suddenly

It is important to never stop Eliquis before your doctor tells you to because this increases your risk of blood clots or stroke. The medication does not stay in your system long after you stop taking it.

The clot-fighting effects of Eliquis begin to wear off in about 24 hours after your last dose. This means your protection against dangerous clots disappears quickly if you miss doses or stop treatment.

If you need to stop Eliquis for surgery or due to bleeding complications, your doctor will provide specific instructions about timing and whether you need alternative blood-thinning options.

Managing Long-Term Eliquis Treatment

Many patients successfully take Eliquis for years with proper monitoring and lifestyle adjustments. Here are key strategies for long-term success:

• Regular medical monitoring: Your doctor will schedule periodic check-ups to assess your continued need for treatment and monitor for complications.
• Consistent dosing: Take Eliquis at the same times each day to maintain steady blood levels and optimal protection.
• Bleeding awareness: Learn to recognize signs of serious bleeding and know when to seek immediate medical attention.
• Drug interaction management: Always inform healthcare providers that you take Eliquis before starting new medications or supplements.

Some patients stop blood thinners prematurely due to minor bleeding issues or lifestyle concerns. However, working with your healthcare team to manage side effects is usually safer than stopping protection against life-threatening clots.

Monitoring and Adjusting Treatment

Unlike warfarin, Eliquis does not require regular blood testing to monitor its effectiveness. However, your doctor will still want to see you periodically to evaluate your ongoing treatment needs.

During these visits, your healthcare provider will assess:

• Whether your underlying condition still requires anticoagulation
• Your current bleeding risk compared to clot risk
• How well you are tolerating the medication
• Any changes in other medications or health conditions
• Your kidney function, as this affects how Eliquis is eliminated from your body

Based on this evaluation, your doctor may continue current treatment, adjust your dose, or, in some cases, recommend stopping the medication if your risk-benefit profile has changed significantly.

Cost Considerations for Long-Term Use

Long-term Eliquis treatment can represent a significant ongoing expense, especially for patients without adequate insurance coverage. The cost of brand-name Eliquis may be substantial when taken for months or years.

Patients concerned about affording long-term treatment should discuss options with their healthcare provider and pharmacist. Universal Drugstore offers reliable access to medications at competitive cash-pay prices, which can be particularly valuable for patients needing long-term anticoagulation therapy. Universal Drugstore also has access to generic Eliquis from licensed international pharmacies.

Some patients may be candidates for generic alternatives or other anticoagulants that offer similar protection at different price points, depending on their specific medical situation.

When Treatment May End

While many patients need long-term or lifelong Eliquis treatment, there are situations where discontinuation may be appropriate:

• Temporary risk factors resolve: If your clot risk was related to a specific event like surgery, immobilization, or pregnancy, treatment may end once the risk period passes.
• Bleeding complications: Serious bleeding events may require stopping anticoagulation, though this decision involves careful risk assessment.
• Major surgery requirements: Some surgical procedures require temporary or permanent discontinuation of blood thinners.
• Significant changes in health status: Advanced illness or other conditions may alter the risk-benefit calculation for continued anticoagulation.

Any decision to stop Eliquis should always involve thorough discussion with your healthcare provider about alternative protection strategies and ongoing monitoring needs.

Working With Your Healthcare Team

The question of how long you can stay on Eliquis does not have a universal answer. Your treatment duration should be personalized based on your medical history, current health status, and individual risk factors.

Maintain open communication with your healthcare provider about:

• Any bleeding episodes or concerning symptoms
• Changes in other medications or supplements
• Lifestyle changes that might affect your clot or bleeding risk
• Questions about treatment duration or alternatives
• Concerns about cost or access to medication

Remember that the goal of Eliquis treatment is to provide the best balance of protection against dangerous clots while minimizing bleeding risk. This balance may change over time, and your treatment plan should evolve accordingly under medical supervision.

References

• Eliquis (apixaban) tablets, for oral use [package insert]. Bristol Myers Squibb. Last updated 4/2025. Accessed June 12, 2026.
• Apixaban (Oral Route) – Mayo Clinic. Mayo Clinic. Accessed June 12, 2026.
• Long-Term Blood Thinner Use: What You Need to Know. Healthline. Accessed June 12, 2026.
• Living Your Best Life While Taking Blood Thinners. National Blood Clot Alliance. Accessed June 12, 2026.